Brief: CanSino Biologics Posts H1 Gross Profit of RMB296.6 MLN
20/08/2025 12:12
Aug 20 (Reuters) - CanSino Biologics Inc 688185.SS: CANSINO BIOLOGICS H1 REVENUE RMB 374.1 MILLION CANSINO BIOLOGICS H1 GROSS PROFIT RMB 296.6 MILLION Further company coverage: 688185.SS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025